Sven Epple, Ph.D., is an Investigator at GSK, specializing in the design and synthesis of novel nucleic acid therapeutics. With a DPhil from the University of Oxford, Sven developed backbone-modified oligonucleotides and contributed to prestigious journals. Previously, Sven held roles as an oligonucleotide chemist at Biocrucible and a manufacturing scientist at ATDBio, focusing on scale-up and analysis of oligonucleotides. Currently, Sven serves as a Senior Scientist at Roche, leading oligonucleotide lead optimization efforts.
Location
Switzerland
This person is not in the org chart
This person is not in any teams